Pharm of Drugs in Lower GI Flashcards
2 classes of drugs that stimulate the ENS (for constipation)
Laxatives (bulk, osmotic, stimulant)
Opioid receptor antagonists
Bulk Laxatives
Introduction of indigestible, water absorbing molecules
Intestinal distention leading to ENS stimulation of peristalsis
Through dietary fiber or supplemental intake (methycellulose, psyllium husk)
Osmotic laxatives
Poorly absorbed salts that retain and/or draw water back into the colon via osmosis
Increased stimulation of peristalsis
Some may have additional effectiveness as stool softeners
Ex: salts and sugars, polyethelene glycol (know this name)
Side effects of osmotic laxatives
Electrolyte imbalance (salts only) Bloating and/or flatulence Abdominal cramps and/or diarrhea
Stimulant/Contact laxatives
Direct stimulation of myenteric plexus in ENS
Increases smooth muscle motility and evacuation of contents
Ex: sennosides, diphenylmethane
Side effects of Stimulant/Contact laxatives
Cramping and/or diarrhea
Pigmentation in colon (thought to be benign)
Should not take castor oil during pregnancy
Stool softeners
Increases surface lubrication of feces (possible penetration of liquid as well)
Soften fecal matter to reduce effort of excretion
Also known as emollients
Ex: glycerin, docusate
Opioid Receptor Antagonists
Selective competitive block of mu-opioid receptors
Prevent opioid-mediated stimulation of GI tract
Used for opioid-induced constipation
Ex: methylnaltrexone
Subcutaneous administration
Do not cross the BBB (peripherally selective effective) - no analgesic effect
Contraindications and side effects of opioid-receptor antagonists
Contraindicated in: Known or suspected GI blockage
Side effects: abdominal pain/cramping, diarrhea and/or flatulence, nausea
Opioid induced constipation line of therapies
Laxatives and stool softeners as first line
Progress to opioid receptor antagonists and/or Cl channel activators (lubiprostone)
Antimotility agents for diarrhea
Ex: loperamide (selective mu opioid receptor agonist)
Inhibition of ENS activity leading to increased colonic transport time and water absorption
Does not readily cross BBB (peripherally selective)
Does not appear to produce tolerance
Loperamide
Selective mu opioid receptor agonist
Used for acute non-infectious diarrhea or chronic diarrhea
Inhibition of ENS activity leading to increased colonic transport time and water absorption
Bismuth subsalicylate
Antisecretory effects
Reduction of intestinal prostaglandin production (reduced motility) and reduced Cl secretion (reduced liquidity)
Antimicrobial effects
Theory of treatment for IBS
Manage symptoms
Constipation, diarrhea, pain, bloating, cramping
Aminosalicylates
5-aminosalicylate Anti-inflammatory through a variety of possible mechanisms: NSAID-like inhibition of prostaglandins Interfere with cytokine porduction Reduced leukocyte activity